161 related articles for article (PubMed ID: 7387207)
1. [Experiments of the viloxazine-noradrenaline interaction on the atrium and the isolated ductus defens of the rat. Comparison with imipramine].
García Morillas M; Puche E; Mundo A; Arias A
Arch Farmacol Toxicol; 1980 Apr; 6(1):83-8. PubMed ID: 7387207
[No Abstract] [Full Text] [Related]
2. [Activity of nomifensine on the effects induced by noradrenaline on the atrium and the isolated ductus deferens of the rat].
Puche E; García Morillas M; Mundo A; Saucedo R; Revelles H
Arch Farmacol Toxicol; 1980 Apr; 6(1):89-93. PubMed ID: 7387208
[No Abstract] [Full Text] [Related]
3. A comparison of the effect of cocaine desipramine on the contractions of the isolated vas deferens of the rat induced by dopamine and noradrenaline [proceedings].
Tayo FM
West Afr J Pharmacol Drug Res; 1977 Jun; 4(1):74P-75P. PubMed ID: 602198
[No Abstract] [Full Text] [Related]
4. 2-(Methyleneaminoxy)methylmorpholine derivatives. Synthesis and antidepressant activity.
Balsamo A; Lapucci A; Macchia M; Martinelli A; Nencetti S; Rossello A; Cristina T
Farmaco; 1994 Feb; 49(2):77-82. PubMed ID: 8003184
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of desipramine in the vas deferens and potentiation of noradrenaline response.
Binini R; Bonaccorsi A; Garattini S; Morselli PL; Muscettola GB
Br J Pharmacol; 1971 Feb; 41(2):390P-391P. PubMed ID: 5572290
[No Abstract] [Full Text] [Related]
6. [Maximal response of the rat vas deferens. III. Effect of compounds with various pharmacological activities on the response to noradrenaline].
Grana E; Zonta F; D'Agostino G
Farmaco Sci; 1980 Dec; 35(12):1021-33. PubMed ID: 7202700
[TBL] [Abstract][Full Text] [Related]
7. [Influence of various antidepressive agents on the peripheral actions of noradrenaline].
Cuenca E; Estaban J; Gibert Fahola J; Serrano MI; Micó JA
Arch Farmacol Toxicol; 1979 Dec; 5(3):154-6. PubMed ID: 546332
[No Abstract] [Full Text] [Related]
8. Actions of lofexidine on isolated heart and smooth muscle preparations.
Graf E
Arzneimittelforschung; 1982; 32(8a):923-30. PubMed ID: 6890366
[No Abstract] [Full Text] [Related]
9. Effect of fluoxetine (Lilly II0I40) on serotonin, noradrenaline and acetylcholine in isolated organs.
Cortés A; Merino G; Contreras E
Cell Mol Biol Incl Cyto Enzymol; 1978; 23(2):179-82. PubMed ID: 309793
[No Abstract] [Full Text] [Related]
10. Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.
Burt RP; Chapple CR; Marshall I
Br J Pharmacol; 1998 Jan; 123(2):317-25. PubMed ID: 9489621
[TBL] [Abstract][Full Text] [Related]
11. In vitro interactions of the new anorexic agent WY-5244 with cardiac and vascular tissue and with adrenergic mechanisms.
Baum T; Gluckman MI
J Pharmacol Exp Ther; 1967 Dec; 158(3):510-8. PubMed ID: 5624080
[No Abstract] [Full Text] [Related]
12. The effects of mianserine, amitriptyline, ciclazindol and viloxazine on presynaptic alpha-receptors in isolated rat atria [proceedings].
Gardner CR; Wilford AE
Br J Pharmacol; 1980 Jan; 68(1):184P-185P. PubMed ID: 6244029
[No Abstract] [Full Text] [Related]
13. [The mechanism of catecholamine potentiation of guinea pig seminal duct contractions].
Avakian OM; Pogasian AV
Farmakol Toksikol; 1972; 35(6):684-7. PubMed ID: 4651800
[No Abstract] [Full Text] [Related]
14. [Pharmacodynamic properties of prenylamine].
Grana E; Mallucci C; Zonta F; Santagostino Barbone MG
Farmaco Prat; 1978 Jun; 33(6):241-55. PubMed ID: 570512
[No Abstract] [Full Text] [Related]
15. [Comparative effects of various antidepressants on the response to noradrenaline of the deferent canal and the arterial pressure, and the response to 5-hydroxytryptamine of the rat uterus].
Van Dorsser W; Dresse A
Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):373-6. PubMed ID: 4848332
[No Abstract] [Full Text] [Related]
16. [Interaction of tricyclic antidepressants with noradrenaline and 5-hydroxytryptamine in peripheral preparations of the rat].
Van Dorsser W; Dresse A
Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):164-76. PubMed ID: 952575
[TBL] [Abstract][Full Text] [Related]
17. Evidence for catecholamine-depleting action of fluoxetine.
Patil MR; Satia MC; Mehta AA; Goyal RK
Indian J Physiol Pharmacol; 1994 Jul; 38(3):169-73. PubMed ID: 7814076
[TBL] [Abstract][Full Text] [Related]
18. An evidence for the central serotoninergic activity of viloxazine.
Pawłowski L; Ruczyńska J; Wojtasik E
Pol J Pharmacol Pharm; 1979; 31(4):261-9. PubMed ID: 523336
[TBL] [Abstract][Full Text] [Related]
19. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.
Lippman W; Pugsley TA
Can J Physiol Pharmacol; 1976 Aug; 54(4):494-509. PubMed ID: 974878
[TBL] [Abstract][Full Text] [Related]
20. A new type of drug enhancement: increased maximum response to cumulative noradrenaline in the isolated rat vas deferens.
Barnett A; Greenhouse DD; Taber RI
Br J Pharmacol Chemother; 1968 May; 33(1):171-6. PubMed ID: 5660158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
